Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1997 Apr;225(4):355–364. doi: 10.1097/00000658-199704000-00003

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.

Y P Le Treut 1, J R Delpero 1, B Dousset 1, D Cherqui 1, P Segol 1, G Mantion 1, L Hannoun 1, G Benhamou 1, B Launois 1, O Boillot 1, J Domergue 1, H Bismuth 1
PMCID: PMC1190742  PMID: 9114793

Abstract

OBJECTIVE: The purpose of this study was to assess the value and timing of orthotopic liver transplantation (OLT) in the treatment of metastatic neuroendocrine tumors (NET). SUMMARY BACKGROUND DATA: Liver metastasis from NET seems less invasive than other secondary tumors. This observation suggests that OLT may be indicated when other therapies become ineffective. However, the potential benefit of this highly aggressive procedure is difficult to assess due to the scarcity and heterogeneity of NET. METHODS: A retrospective multicentric study was carried out, including all cases of OLT for NET performed in France between 1989 and 1994. There were 15 cases of metastatic carcinoid tumor and 16 cases of islet cell carcinomas. Hormone-related symptoms were present in 16 cases (55%). Only 5 patients (16%) had no previous surgical or medical therapy before OLT. Median delay from diagnosis of liver metastasis and OLT was 19 months (range, 2 to 120). RESULTS: The primary tumor was removed at the time of OLT in 11 cases, by upper abdominal exenteration in 7 cases and the Whipple resection in 3. Actuarial survival rate after OLT was 59% at 1 year, 47% at 3 years, and 36% at 5 years. Survival rates were significantly higher for metastatic carcinoid tumors (69% at 5 years) than for noncarcinoid apudomas (8% at 4 years), because of higher tumor- and non-tumor-related mortality rates for the latter. CONCLUSION: OLT can achieve control of hormonal symptoms and prolong survival in selected patients with liver metastasis of carcinoid tumors. It does not seem indicated for other NET.

Full text

PDF
355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alessiani M., Tzakis A., Todo S., Demetris A. J., Fung J. J., Starzl T. E. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995 Jan;180(1):1–9. [PMC free article] [PubMed] [Google Scholar]
  2. Alsina A. E., Bartus S., Hull D., Rosson R., Schweizer R. T. Liver transplant for metastatic neuroendocrine tumor. J Clin Gastroenterol. 1990 Oct;12(5):533–537. doi: 10.1097/00004836-199010000-00009. [DOI] [PubMed] [Google Scholar]
  3. Anthuber M., Jauch K. W., Briegel J., Groh J., Schildberg F. W. Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg. 1996 Jan;20(1):73–76. doi: 10.1007/s002689900013. [DOI] [PubMed] [Google Scholar]
  4. Arnold J. C., O'Grady J. G., Bird G. L., Calne R. Y., Williams R. Liver transplantation for primary and secondary hepatic apudomas. Br J Surg. 1989 Mar;76(3):248–249. doi: 10.1002/bjs.1800760311. [DOI] [PubMed] [Google Scholar]
  5. Bramley P. N., Lodge J. P., Losowsky M. S., Giles G. R. Treatment of metastatic Vipoma by liver transplantation. Clin Transplant. 1990 Oct;4(5 Pt 1):276–279. [PubMed] [Google Scholar]
  6. Carty S. E., Jensen R. T., Norton J. A. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery. 1992 Dec;112(6):1024–1032. [PubMed] [Google Scholar]
  7. Curtiss S. I., Mor E., Schwartz M. E., Sung M. W., Hytiroglou P., Thung S. N., Sheiner P. A., Emre S., Miller C. M. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg. 1995 Feb;180(2):184–187. [PubMed] [Google Scholar]
  8. Dousset B., Houssin D., Soubrane O., Boillot O., Baudin F., Chapuis Y. Metastatic endocrine tumors: is there a place for liver transplantation? Liver Transpl Surg. 1995 Mar;1(2):111–117. doi: 10.1002/lt.500010208. [DOI] [PubMed] [Google Scholar]
  9. Gulanikar A. C., Kotylak G., Bitter-Suermann H. Does immunosuppression alter the growth of metastatic liver carcinoid after orthotopic liver transplantation? Transplant Proc. 1991 Aug;23(4):2197–2198. [PubMed] [Google Scholar]
  10. Ihse I., Persson B., Tibblin S. Neuroendocrine metastases of the liver. World J Surg. 1995 Jan-Feb;19(1):76–82. doi: 10.1007/BF00316983. [DOI] [PubMed] [Google Scholar]
  11. Kwekkeboom D. J., Krenning E. P. Somatostatin receptor scintigraphy in patients with carcinoid tumors. World J Surg. 1996 Feb;20(2):157–161. doi: 10.1007/s002689900024. [DOI] [PubMed] [Google Scholar]
  12. Lobe T. E., Vera S. R., Bowman L. C., Fontanesi J., Britt L. G., Gaber A. O. Hepaticopancreaticogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood. J Pediatr Surg. 1992 Feb;27(2):227–229. doi: 10.1016/0022-3468(92)90317-z. [DOI] [PubMed] [Google Scholar]
  13. Makowka L., Tzakis A. G., Mazzaferro V., Teperman L., Demetris A. J., Iwatsuki S., Starzl T. E. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet. 1989 Feb;168(2):107–111. [PMC free article] [PubMed] [Google Scholar]
  14. McDermott E. W., Guduric B., Brennan M. F. Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg. 1994 Jul;81(7):1007–1009. doi: 10.1002/bjs.1800810725. [DOI] [PubMed] [Google Scholar]
  15. Mieles L., Todo S., Tzakis A., Starzl T. E. Treatment of upper abdominal malignancies with organ cluster procedures. Clin Transplant. 1990 Apr;4(2):63–67. [PMC free article] [PubMed] [Google Scholar]
  16. Moertel C. G. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol. 1987 Oct;5(10):1502–1522. doi: 10.1200/JCO.1987.5.10.1502. [DOI] [PubMed] [Google Scholar]
  17. Olthoff K. M., Millis J. M., Rosove M. H., Goldstein L. I., Ramming K. P., Busuttil R. W. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990 Oct;125(10):1261–1268. doi: 10.1001/archsurg.1990.01410220045007. [DOI] [PubMed] [Google Scholar]
  18. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991 Oct;110(4):726–735. [PubMed] [Google Scholar]
  19. Pichlmayr R., Weimann A., Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology. 1994 Jul;20(1 Pt 2):33S–40S. doi: 10.1016/0270-9139(94)90271-2. [DOI] [PubMed] [Google Scholar]
  20. Ringe B., Wittekind C., Bechstein W. O., Bunzendahl H., Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg. 1989 Jan;209(1):88–98. doi: 10.1097/00000658-198901000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Routley D., Ramage J. K., McPeake J., Tan K. C., Williams R. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver. Liver Transpl Surg. 1995 Mar;1(2):118–121. doi: 10.1002/lt.500010209. [DOI] [PubMed] [Google Scholar]
  22. Schweizer R. T., Alsina A. E., Rosson R., Bartus S. A. Liver transplantation for metastatic neuroendocrine tumors. Transplant Proc. 1993 Apr;25(2):1973–1973. [PubMed] [Google Scholar]
  23. Starzl T. E., Todo S., Tzakis A., Podesta L., Mieles L., Demetris A., Teperman L., Selby R., Stevenson W., Stieber A. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg. 1989 Sep;210(3):374–386. doi: 10.1097/00000658-198909000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Taranto D., Suozzo R., Romano M., di Sapio M., Caporaso N., Del Vecchio Blanco C., Coltorti M. Gastric endoscopic features in patients with liver cirrhosis: correlation with esophageal varices, intra-variceal pressure, and liver dysfunction. Digestion. 1994;55(2):115–120. doi: 10.1159/000201135. [DOI] [PubMed] [Google Scholar]
  25. Tsushima K., Nagorney D. M., Weiland L. H., Lieber M. M. The relationship of flow cytometric DNA analysis and clinicopathology in small-intestinal carcinoids. Surgery. 1989 Mar;105(3):366–373. [PubMed] [Google Scholar]
  26. Tzakis A. G., Ricordi C., Alejandro R., Zeng Y., Fung J. J., Todo S., Demetris A. J., Mintz D. H., Starzl T. E. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet. 1990 Aug 18;336(8712):402–405. doi: 10.1016/0140-6736(90)91946-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES